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Objective. To examine the relationship between distance to dialysis provider and
patient selection of dialysis modality, informed by the absolute distance from a
patient’s home and relative distance of alternative modalities.
Data Sources. U.S. Renal Data System.
Study Design. About 70,131 patients initiating chronic dialysis and 4,795 dialysis
facilities in 2006. The primary outcome was patient utilization of peritoneal dialysis
(PD). Independent variables included absolute distance between patients’ home and
the nearest hemodialysis (HD) facility, relative distance between patients’ home and
nearest PD versus nearest HD facilities, and their interaction. Logistic regression was
used to model distance on PD use, controlling for patient and market characteristics.
Principal Findings. Nine percent of incident dialysis patients used PD in 2006. There
was a positive, nonlinear relationship between absolute distance to HD services and
PD use (p < .0001), with the magnitude of the effect increasing at greater distances. In
terms of relative distance, odds of PD use increased if a PD facility was closer or the
same distance as the nearest HD facility (p = .006). Interaction of distance measures to
dialysis facilities was not significant.
Conclusions. Analyses of patient choice between alternative treatments shouldmodel
distance to reflect all relevant dimensions of geographic access to treatment options.
Key Words. Dialysis, geographic distance, treatment selection
Patient distance to medical care services has been shown to influence receipt
of timely care and outcomes (Burgess and DeFiore 1994; Bello et al. 2012;
Harmon et al. 2013; Hayton et al. 2013), particularly for vulnerable patients
who require ongoing care. Close proximity to chronic dialysis services may
ease the travel burden on patients with end-stage renal disease (ESRD) who
require renal replacement therapy for the remainder of their life. In these
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patients, travel distance to care has been associated with patient-reported qual-
ity of life, willingness to comply with treatment regimen, and risk of complica-
tions and death (Willis et al. 1998; Maheswaran et al. 2003; O’Hare,
Johansen, and Rodriguez 2006; Tonelli et al. 2007; Moist et al. 2008; Dia-
mant et al. 2010; Mehrotra et al. 2012; Organ and MacDonald 2014; Chao
et al. 2015).
Patients who are newly diagnosed with kidney failure must choose
between hemodialysis (HD) and peritoneal dialysis (PD), which have different
implications for patient travel due to different in-center treatment require-
ments. HD is primarily performed as a center-based treatment modality
conducted by clinical staff in dialysis facilities at least three times weekly for
about 4 hours per treatment. Among home-based dialysis treatment options
(including hemodialysis), PD is a modality in which patients are trained to per-
form daily self-treatment and requires patients to visit dialysis facilities
monthly for maintenance. In-center HD is the most common form of renal
replacement therapy and offered by almost all dialysis facilities, while PD rep-
resents the overwhelming majority of home-based dialysis utilization in the
United States and is used less often and offered by roughly half of dialysis pro-
viders (O’Hare, Johansen, and Rodriguez 2006; Wang et al. 2010, 2011; US
Renal Data System [USRDS] 2014). Home hemodialysis is not considered fur-
ther in this study.
Research shows that patient choice of dialysis modality is driven by a
myriad of clinical factors (e.g., suitability for self-care, vascular or abdominal
heath) and nonclinical factors (e.g., physician and patient preference, patients’
employment status, social support at home) (Ahlmen, Carlsson, and
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Schonborg 1993; Stack 2002; Hirth et al. 2003; McLaughlin et al. 2003; Gol-
per et al. 2011; Maaroufi et al. 2013). Patients’ education, awareness, and
understanding of these dialysis modalities have also been shown to influence
modality choice (McLaughlin et al. 2003; Golper et al. 2011; Kutner et al.
2011; Blake, Quinn, and Oliver 2013; Ribitsch et al. 2013; Kurella Tamura
et al. 2014). The availability of treatment services in local facilities may play a
role in patients’ awareness of and exposure to different modalities, but it has
received less attention.
Limited availability and access to PD services has been a purported bar-
rier to broad underutilization of PD in the United States (Wang et al. 2010,
2011). Prevalent PD use peaked at 12 percent in 1994 and declined to a current
rate of 6 percent in the United States, compared to 18–73 percent PD use in
other North American, Asian, and European countries (USRDS 2014). The
few studies that examined the role of geographic distance to dialysis in patient
utilization of PD found mixed results. In this paper, we augment data and
methods of prior research to reassess the relationship between patients’ dis-
tance to dialysis treatment and modality choice. Our results can inform
methodological approaches to examining the relationship between geo-
graphic distance and utilization of health services in other contexts.
PREVIOUS RESEARCH ANDHYPOTHESES
Recent research found that patients’ distance to facilities offering HD was neg-
atively associated with PD initiation and distance to PD facilities was posi-
tively associated with PD initiation (Prakash et al. 2014). These findings
contrast earlier observations of higher PD use among patients living in rural
areas, despite less PD availability in rural areas (O’Hare, Johansen, and Rodri-
guez 2006; Tonelli et al. 2007). The mixed findings may arise from varying
analytic approaches used across studies. Earlier analyses did not directly
assess patient distance to dialysis clinics, but rather approximations based on
degree of rurality (O’Hare, Johansen, and Rodriguez 2006) or distance to
physician’s practice (Tonelli et al. 2007). Multivariable modeling of patient
distance in Prakash et al.’s (2014) analysis included separate variables for dis-
tance to nearest home-based and in-center facility and their interaction as well
as distance to center actually attended; however, multicollinearity and con-
founding of the influence of providers’ treatment availability arise when
including the distance to attended facility (i.e., not an exogenous predictor of
choice).
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Appropriate modeling of patients’ geographic access to PD and HD can
be informed by behavioral, economic, and travel distance approaches applied
in prior health services research. Traditional distance or gravity models posit
that patient interest in a treatment decreases as distance to the treatment
increases (Congdon 2001; Cromley and McLafferty 2002). Behavioral
approaches account for patients’ predisposing, need, and enabling characteris-
tics as contributing factors of treatment choice (Andersen and Newman 1973),
whichmaymodify the impact of distance on patient choice of treatments. Eco-
nomic approaches (e.g., conditional choice models) consider the tradeoffs
between travel costs and value of provider’s service options in determining
treatment preferences (Duan et al. 1983; Garnick et al. 1989), such that
patients may be willing to travel further for a high-value service. Common
among these approaches is that any provider offers all alternative treatments,
which is not the case in PD andHD offerings by dialysis facilities.
This analysis of geographic access to alternative dialysis modalities con-
tributes to the literature because of three key differences from prior work.
First, distance is the explanatory variable of interest in this analysis instead of
being modeled as a control variable or in the context of instrumental variables
for outcomes assessment (McClellan, McNeil, and Newhouse 1994; Xian
et al. 2011). Second, most literature has examined distance in the context of
acute inpatient care (Lee and Cohen 1985; Garnick et al. 1989; Burns and
Wholey 1992; McClellan, McNeil, and Newhouse 1994), where patient
choice is time-sensitive. As a result, absolute distance from a patient’s home to
a treatment setting may be the most important aspect of geographic access. In
this study, however, we assess the role of distance on patient choice of dialysis
modality in the context of chronic outpatient treatment (Burgess and DeFiore
1994). Third, accounting for regional treatment use in the prior year likely
avoids a spurious correlation between distance and utilization and reflects
many unobserved influences on treatment choice.
We expect to find three significant relationships between geographic dis-
tance and dialysis treatment choice. First, we expect the relationship between
patients’ absolute distance to a dialysis facility and PD utilization to be nonlin-
ear or even nonmonotonic. For patients who live far from any dialysis facility
(e.g., have large absolute distance), absolute distance to care may not be a sub-
stantial barrier to access for PD. Rather, PD’s self-treatment at home and
monthly visits for dialysis maintenance may make PD an appealing alterna-
tive to thrice-weekly HD. Roughly 20 percent of ESRD patients live far from
themajority of dialysis facilities that tend to be located in urban areas (O’Hare,
Johansen, and Rodriguez 2006;Wang et al. 2010). Patients with small absolute
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distances (e.g., living close to a dialysis facility) may also be less sensitive to the
absolute distance to dialysis treatment (Osterlund et al. 2014).
Second, all dialysis modalities are not available from all providers, so
patient choice of less available PD is constrained. As a result, the relative dis-
tance (between a patient’s home and the nearest PD provider vs. a patient’s
home and the nearest HD provider) is an important aspect of geographic
access and patient choice, in addition to absolute distance. The cumulative tra-
vel distance differs markedly between HD and PD treatment because PD
patients only have a monthly visit to a dialysis facility, but HD patients have
to visit 12–13 times per month. Thus, patients may be quite sensitive to large
differences in the cumulative monthly travel distance between HD and PD
modalities. Patients with a short relative distance, whose nearest HD facility
also offers PD or whose nearest PD facility is in close proximity to the nearest
HD facility, may be indifferent to distance in their modality selection but have
greater “exposure” to PD (i.e., awareness that the same or nearby facilities
offer PD) that may increase uptake of PD. Patients whose relative distance to
PD is high may face barriers to learning about PD and initiate PD at lower
rates than patients with smaller relative distances. As only half of dialysis facili-
ties offer both HD and PD and few facilities only offer PD alone, nearly all
patients live closer to anHD facility than a PD facility. Furthermore, modeling
patient choice as a function of relative distance avoids the potential collinearity
of absolute distance to PD and absolute distance to HD given that PD is
commonlycolocatedwithHD.
Third, the impact of relative distance on patient choice of HD or PD
may also vary depending on patients’ absolute distance to their nearest dialy-
sis facility. Therefore, full exploration of the relationship of geographic access
to dialysis facility and PD initiation should consider interaction of absolute
distance and relative distance to reflect the conditions of patients’ choice set of
provider location and service offerings (Figure 1). Finally, controlling for prior
regional utilization avoids a reverse causality issue, whereby patients in mar-
kets with more PD use (arising from these other factors) have shorter average
distances due to the presence of more PD providers.
In sum, our model considers the functional form of the relationship
between absolute distance and PD use, the significance of relative distance,
whether the relationships between absolute distance and PD use differs when
the relative distance between HD and PD facilities is near or far (i.e., interac-
tion), and controls for prior year PD use at the market level. These method-
ological considerations are applicable to ongoing policy evaluations of
dialysis payment reforms and, more broadly, to analyses of treatment or
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provider choice (e.g., elective outpatient surgery, cancer treatments, provider
ownership type).
METHODS
Sample
We conducted a cross-sectional retrospective study of a cohort of 70,131 newly
diagnosed patients with ESRD initiating chronic dialysis treatment in 2006.
Inclusion criteria were as follows: (1) surviving the first 90 days of dialysis; (2)
having a residence zip code in the United States; (3) receiving dialysis primar-
ily in outpatient-based dialysis facilities (i.e., noninstitutionalized patients); (4)
having complete demographic and clinical information in the patient registry
data; and (5) receiving either in-center hemodialysis or peritoneal dialysis in
2006; (6) aged >19 and <90; and (7) distance to nearest in-center HD facility
≤60 miles. We excluded children because the pediatric ESRD population rep-
resents a small percent of incident ESRD patients whose treatment decisions
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Figure 1: Hypothesized Relationships of Patient Distance to Dialysis
Services and Related Influences on PD Utilization
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are largely age-dependent (e.g., limited access to facilities accepting pediatric
patients, children with ESRD are more likely to receive kidney transplant or
PD treatment). The oldest patients and those living >60 miles from the nearest
dialysis facility represented a very small minority of incident ESRD patients
(<0.01 percent), whose treatment decisions may be driven by different mecha-
nisms compared to the general adult ESRD population. Our sample of dialy-
sis facilities included the 4,795 facilities in the United States that treated
patients with either in-center HD, PD, or both throughout 2006. Patients
receiving home hemodialysis were excluded, as this modality was rare and
not reliably assessed in our study year (USRDS 2009).
Data and Variables
The principal source of data was the U.S. Renal Data System, the repository of
CMS data on ESRD providers and patients. Patient characteristics were
obtained from the Medical Evidence Report (Form CMS-2728), which con-
tains information on all patients initiating, reentering, or changing ESRD ser-
vices (e.g., modality, treating provider). Additional patient information
sources included the PATIENTS file (containing information on patients’ first
date of ESRD service and demographic information) and the RESIDENC file
(providing the zip code of patient residence at the start of ESRD service).
We used the patient treatment history file (RXHIST60) to assess the bin-
ary outcome of PD treatment, based on patients’ treatment modality indicat-
ing PD (USRDS 2009). This inclusive definition considers any use of PD
during the patient’s first calendar year (2006) of dialysis. Dialysis facility’s
location, structural characteristics, treatment service offerings, and operating
statistics came from the Annual Facility Survey (Form CMS-2744). General
market demographic data came from the Area Resource File. We definedmar-
kets as hospital referral regions (HRRs), which approximate the geographic
extent of health care markets for tertiary care (Wennberg and Cooper 1999)
and appear to better reflect PD service areas than municipal designations
because PD patients commonly travel outside county boundaries for monthly
PDmaintenance visits.
Independent variables of interest included two distance measures, calcu-
lated as straight-line distances from patients’ and dialysis facilities’ zip code
centroids. First, we ascertained the absolute distance between each patient’s
home at dialysis initiation and the nearest facility offering HD. Absolute
distance references HD services because virtually all dialysis units offer HD.
Because absolute distance to closest HD facility was skewed with a significant
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percentage with a distance of 0 (38 percent), we included both (1) a continuous
distance variable to closest HD facility and (2) a dichotomous variable for dis-
tance to closest HD facility of zero versus greater than zero to improve model
fit (Hosmer and Lemeshow 2000). Second, we calculated the relative distance
between patients’ nearest facilities offering PD and HD services, defined as
the difference of patients’ absolute distance to their closest PD facility versus
HD facility. By reflecting patients’ differential distance to facilities that offer
HD or PD or both, this second measure implicitly accounts for patients’ abso-
lute distance to PD provider in a way that is interpretable and reduces the
problem of collinearity in regression models. Approximately, 47 percent of
patients had a relative distance of zero (where closest PD and HD facilities
were in the same facility or zip code), and 45 percent had a relative distance
>0 but <20 miles. Because only 0.6 percent of patients had a negative value of
relative distance a results of few facilities offering only PD, we dichotomized
relative distance: “1” if the nearest PD facility was closer or the same distance
as the nearest HD facility and “0” if PD was farther than HD service.
Analyses controlled for other characteristics of patients, facilities, and
regional markets that may influence treatment choice (Ahlmen, Carlsson, and
Schonborg 1993; Stack 2002; Kutner et al. 2011). Patient demographic char-
acteristics at dialysis initiation included age, gender, race (white, black, other),
full- or part-time employment status at onset of ESRD, and urban/rural
residence. Patient-level clinical covariates included receipt of pre-ESRD
nephrologist care, diabetes as the cause of ESRD, BMI, and comorbidity indi-
cators (e.g., diabetes, hypertension, heart disease). Market characteristics for
patient’s region included market-level PD prevalence in 2005 (numbers of
patients receiving PD per 1,000 ESRD prevalent population per HRR), pro-
portion of dialysis facilities affiliated with a large chain organization, the
percentage of facilities in urban locations, and overall market size (population
density). Market-level PD prevalence in 2005 was included to account for
patient exposure to PD services that may influence its uptake and to reduce
the risk that the distance coefficients were biased due to a correlation between
high market-level use and low distance to PD providers.
Analysis
A logistic regression model of PD use was fit to examine the relationships of
continuous absolute distance to closest HD facility and dichotomized relative
distance between closest HD facility and PD facility, adjusting for patient and
42 HSR: Health Services Research 52:1, Part I (February 2017)
market characteristics. An interaction term between absolute distance to clos-
est HD facility and relative distance was also included.
We examined the assumption of linearity of the logit for all continuous
variables, including absolute distance to closest HD, using fractal polynomial
models (Hosmer and Lemeshow 2000). Fractal polynomial models are a gen-
eral family of parametric models based on one or two terms of the form X p,
where the exponents (p) are chosen from a predefined set providing a class of
possible functional forms that lead to satisfactory fit to the data in many situa-
tions (Sauerbrei et al. 2006). The SAS macro MFP (Multivariable Fractal
Polynomial) was implemented to determine appropriate transformations.
Model fit was poor when assuming linearity (Hosmer–Lemeshow good-
ness-of-fit statistic p = .02), while model fit for the final model including fractal
polynomial transformations for all continuous predictors was improved
(p = .32). Transformation of absolute distance to closest HD with inverse
square root (X0.05) and quadratic (X2) terms optimized the predictive value of
absolute distance on PD use, which avoided underestimation of the slope for
smaller distances and overestimation of the slope for larger distances by allow-
ing the rate of change in the odds of PD use to vary across the continuum of dis-
tance. The final logistic model had reasonable predictive power with a
C-statistic of 0.75.
To interpret the relationship of distance to closest HD facility and rela-
tive distance between HD and PD facilities, predicted odds ratios of PD uti-
lization and associated 95 percent confidence intervals were calculated for
different values of absolute and relative distances. The study was approved by
the Institutional Review Board of Duke University Health System.
RESULTS
Descriptive Statistics
Of the 70,131 who initiated dialysis in 2006, 9 percent used PD in 2006
(Table 1). PD patients were younger and more likely to be white, employed,
and have pre-ESRD nephrology care compared to HD patients. The majority
of patients resided in urban locations, with slightly less urbanicity among
those on PD (75 percent on PD vs. 80 percent on HD). Patients on PD lived in
regions with higher PD prevalence and a greater proportion of facilities offer-
ing PD.Mean (median) absolute distance to the nearest dialysis facility of both
types of modality was greater for PD patients than those on HD—5.9 (3.0)
miles versus 4.1 (1.9) miles to nearest HD facility and 10.8 (5.3) miles versus
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9.4 (4.2) miles to nearest PD facility. Mean (median) relative distance between
nearest dialysis facilities offering PD and HD services was 4.9 (0.0) miles for
PD and 5.4 (0.4) miles HD patients.
Figure 2 illustrates PD utilization by discrete categories of absolute dis-
tance to nearest HD facility by category of relative distance. For distances
greater than 0 as categories of distance increased, PD use generally increased.
Table 1: Incident ESRD Patient Characteristics, 2006 (N = 70,131)
By Dialysis Modality
Overall Sample
Mean (SD) or %
PD
(N = 6,099)
HD
(N = 64,032)
Patient characteristics
Age 62.0 (14.9) 57.8 (14.9) 62.4 (14.8)
Male (%) 55.9 55.1 56.0
Race
White (%) 64.7 72.8 63.9
Black 29.8 21.1 30.6
Other 5.5 6.1 5.5
Employed (full-time or part-time) (%) 12.3 25.5 11.1
Urban residence (%) 79.6 75.0 80.0
Pre-ESRD nephrologist care (%) 68.8 87.7 67.0
Cause of ESRD: Diabetes (%) 48.3 44.7 48.7
BMI 28.9 (7.6) 28.8 (6.7) 28.9 (7.7)
Comorbid conditions
Diabetes 54.1 48.5 54.6
Hypertension 85.9 87.5 85.8
Coronary artery disease 22.6 17.2 23.1
Cerebrovascular disease 9.1 6.1 9.4
Peripheral vascular disease 14.4 10.5 14.7
Other cardiac disease 14.7 11.1 15.1
Congestive heart failure 32.8 19.8 34.0
Chronic obstructive pulmonary disease 8.3 4.8 8.6
Cancer 7.0 5.1 7.2
Distance
Absolute distance to closest HD 4.2 (6.6) 5.9 (8.3) 4.1 (6.4)
Absolute distance to closest PD 9.6 (15.8) 10.8 (15.7) 9.4 (15.8)
Relative distance: closest PD–HD 5.3 (13.9) 4.9 (12.5) 5.4 (14.0)
Relative distance: nearest PD is
closer or the same distance as
nearest HD (%)
47.6 51.1 47.2
Market characteristics (HRR)
PD prevalence in prior year 61.6 (24.3) 71.9 (27.2) 60.7 (23.8)
% facilities in urban location 78.8 (16.7) 75.7 (16.9) 79.1 (16.6)
% facilities: chain affiliated 67.2 (24.8) 68.5 (25.2) 67.1 (24.7)
Population density 1,169.4 (566.6) 594.7 (813.4) 1,124.1 (685.8)
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In general, PD use was higher when PD was located closer or the same dis-
tance as the patients’ nearest facility offering HD (relative distance ≤0)
compared to when PDwas located farther away.
Logistic Model Results
Absolute distance to the closest HD facility (v23 = 81.9, p < .0001), dichoto-
mized absolute distance to closest HD of zero miles (v21 = 11.7, p = .0006),
and relative distance between PD and HD facilities (v21 = 7.5, p = .006) were
significantly associated with PD use. The interaction between absolute and rel-
ative distance was not significant (p = .13, Figure 3).
Figure 3 illustrates the relationships between PD utilization and
different absolute distances compared to a reference of zero miles.
Absolute distances of 1–3 miles were not associated with greater PD
use, and only became a significant predictor of PD use for absolute
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Figure 2: Unadjusted Rates of PD Utilization, by Discrete Categories of
Patients’ Absolute Distance to Nearest Hemodialysis Facility and Relative
Distance Category (number of patients for each of the two categories of rela-
tive distance shown on top and below bars)
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distances >3 miles. The odds of PD initiation were greater (odds ratio
[OR] = 1.3; 95 percent CI 1.2, 1.4) when the absolute distance from
home to the closest HD facility increased from zero to 5 miles. The
odds of PD initiation increased roughly threefold when the absolute
distance from home to the closest HD facility increased from zero to
50 miles (OR = 3.2; 95 percent CI 2.1, 4.6).
Estimated odds of PD use were somewhat greater if PD was closer or the
same distance as the nearest HD (i.e., relative distance ≤0). Although the inter-
action was not statistically significant, the estimated odds of PD use were
slightly lower if patients’ nearest PD facility was located further than the near-
est HD facility (i.e., relative distance >0) at absolute distances of 3–35 miles.
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Figure 3: Adjusted Results: Predicted Odds of PD Utilization
Notes: Estimated odds ratio and 95 percent confidence limits comparing distance to closest HD
facility from 1–50 to 0 miles to closest HD facility (in the same zip code) when distance to closest
PD facility is either the same or closer thanHD facility (red) or distance to closet PD is farther than
closest HD (blue).
Although the interaction (absolute distance relative distance) is not statistically significant
(p = .13), we present results within the structure of our formal hypothesis tests. Adjusted
model also controlled for patient characteristics: age, gender, race, employment status,
urban/rural residence, receipt of pre-ESRD nephrology care, body mass index, comorbid
conditions, and cause of ESRD as well as market-level characteristics: PD prevalence rate
in prior year, dialysis facility composition, and general population density (fractal polyno-
mial transformations results for other continuous predictors not shown). Estimates from the
full model are available in Appendix SA2.
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The effect of relative distance flips at farther distances, which may be due to
nonlinearity of distance to nearest HD in PD use and/or the sparseness of data
at larger distances to nearest HD.
DISCUSSION
This study examined the influence of geographic access to dialysis facilities
on patient selection of peritoneal dialysis in terms of absolute and relative
distance. To our knowledge, this is the first study that considers more fully
the conditions of patients’ choice of service and provider locations in deter-
mining utilization of dialysis modalities. Findings from this analysis have
implications on conceptualizing and understanding the impacts of dialysis
service supply.
We found that 9 percent of incident dialysis patients used PD in 2006
and that patients’ absolute distance to care is an important factor in initiation
of PD, particularly for those living farther away from more commonly offered
HD services. Absolute distance to HD services was a significant predictor of
PD use in distances >3 miles and its effects increased in magnitude at absolute
distances of 35–50 miles, confirming a nonlinear relationship between abso-
lute distance to dialysis facilities and modality choice. Our results contrast
with a more recent analysis, which found longer absolute distance to patients’
nearest HD associated with decreased odds of PD use (Prakash et al. 2014).
These differences are likely due to the ways in which distance and patients’
choice set was modeled to account for non–mutually exclusive treatment ser-
vice availability at potential providers. This is an important consideration
because dialysis facilities may offer a range of treatment options, from exclu-
sive provision of HD or exclusive PD (rarely), or both. Instead of including an
additional measure of absolute distance to PD provider, we included relative
distance to simultaneously represent patients’ differential distance and treat-
ment service availability (HD vs. PD) to nearest providers. Our analysis con-
firmed the significance of modeling absolute distance to HD and differential
distance between PD andHD.
Altogether, our results indicate that proximity is an important factor for
patients considering dialysis care, but not in the ways that policy makers and
researchers traditionally think about access to care. Instead of distance acting
only as a barrier to treatment services in a monotonic fashion, longer absolute
distances are associated with different choices in treatment. If we accept the
premise that PD is underutilized on average, then greater distance might
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“nudge” the dialysis population closer to an ideal mix of treatment modalities
even if it represents a barrier to some individuals. This is consistent with
earlier studies that found higher rates of PD use in rural regions, which typi-
cally have less PD supply than urban areas (O’Hare, Johansen, and Rodriguez
2006) as well as commonly noted logistical advantages and appeal of PD for
patients in remote areas or lacking adequate transportation. This relationship
is influenced in part by the home-based, self-management of PD and the less
frequent visits to providers (Osterlund et al. 2014).
Distance to dialysis facilities was associated with PD uptake among
patients living moderate to longer distances from dialysis facilities, but
patients residing close by dialysis units (0–3 miles) were relatively indifferent
to distance. This is particularly interesting because the majority of dialysis
patient and dialysis facilities are located in urban locations. The significance of
relative distance (i.e., when patients’ nearest PD facility was closer or the same
distance as the nearest facility) and regional PD prevalence (Appendix SA2)
indicates that the availability of PD services and utilization may play a role in
patients’ awareness and exposure to PD to influence its use but, for the major-
ity of dialysis markets with a high population and density of providers, other
factors influence modality choice besides PD supply and distance.
For policy and planning, Medicare’s 2011 ESRD bundled payment
reform for dialysis services that is expected to induce greater demand for and
access to PD services (GAO 2009; Hornberger and Hirth 2012; Hirth et al.
2013) may have limited impacts on increasing new supply and access to PD
for patients in micropolitan and rural areas. Findings from prior work and this
analysis, conducted before the current era of the ESRD bundle, suggest a strat-
egy of locating PD in urban locations that do not preclude patients traveling
from afar for less frequent PD visits than HDwhile, at the same time, allowing
urban facilities to benefit from their proximity to most HD and PD patients
(Wang et al. 2011). The results presented here may serve as a benchmark to
examine where policy has the greatest impact in PD utilization and patient
access.
Results from this analysis also have important implications for health
services research focused on patient travel distance more broadly. The con-
cepts and methods from this analysis may inform similar studies examining
patient selection of providers and alternative modalities of treatment that are
not equally available across providers, such as elective procedures, new sur-
gical techniques, or advanced imaging technologies. For example, patients
facing longer travel distances to breast cancer treatment have higher rates of
mastectomy than frequently administered radiotherapy treatment, compared
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to patients who travel shorter distances for treatment (Canadian Institute for
Health Information 2012). Analyses of utilization must appropriately model
access to reflect logistical implementation of treatment options and the ser-
vice options available to patients. In addition, absolute or relative distance
has been used as an instrumental variable (IV) in analyses of other outcomes.
Distance strongly predicts choice of provider in various clinical contexts
(McClellan, McNeil, and Newhouse 1994; Zwanziger, Mukamel, and Indri-
dason 2002; Hirth et al. 2003, 2014; Brooks et al. 2006; Shugarman and
Brown 2006; Grabowski et al. 2013). In the dialysis context, Brooks et al.
(2006) found the relative proximity to for-profit and nonprofit dialysis facili-
ties to be the strongest predictor of the type of facility chosen, and that use of
this measure as an IV eliminated the relationship between ownership and
patient survival that existed in observational data. Similarly, Hirth et al.
(2006) used differential distance to predict PD use, which was then used to
predict patient employment status, showing that PD facilitated employment,
but to a lesser extent than would be indicated by the observational correla-
tion. The current study demonstrates that more complex relationships
between distance and provider choice (e.g., using indicators of both absolute
and relative distance as well as interactions; accounting for market-level vari-
ations in treatment use that could arise from nondistance factors) could
enhance the performance of distance as an instrumental variable in other
contexts.
Our study has several limitations. First, patient distances of 0 miles to
nearest dialysis units in our study are not realistically feasible and the con-
siderable proportion of patients living in the same zip code as their nearest
dialysis facility (i.e., many ESRD patients live in urban locales, where dialy-
sis facilities are typically located) affected our model specification. Location
data in the USRDS were limited to zip code and distance measures, based
on zip code centroids, inhibited precise measurement of distance. This adds
some measurement error, particularly at small distances, so the 0–3 mile
results should be interpreted cautiously. Second, our construction of dis-
tance measures was based on straight-line distance instead of travel distance
(based on actual road and traffic patterns) or travel time that may mask true
impacts of distance and relative distance. However, analysis of hospital
choice has demonstrated a high correlation between straight-line and travel
distance (Phibbs and Luft 1995; Boscoe, Henry, and Zdeb 2012). Third, the
2006 data used for this study may not reflect current rates of PD use and
did not allow for examining initiation of home-based HD, which, although
still far less common than PD as a home therapy modality, has become
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increasingly popular in recent years. This heuristic study sample contained
the most recent patient and provider data available to the authors and suit-
able for analysis. However, our findings may suggest similar relationships
between distance and home-based HD, which can be formally tested when
more recent data that also contain more reliable assessment of home HD
become available. Last, while our analysis controlled for regional use of PD
among patients, we were not able to account directly for physician supply
or physician practice patterns, which may explain variation in PD use.
Future research may consider incorporating additional physician-level data
to examine the extent to which physician referral modifies the relationship
between distance and treatment selection.
In this paper, we refined measurement and modeling of patient distance
to care to assess the extent to which and for whom distance to dialysis services
influenced choice of dialysis modality. The methodological considerations
underlying the inclusion of absolute and relative distance to different treat-
ment options are important to forthcoming policy evaluations of dialysis pay-
ment reforms to inform efforts to promote increased utilization of an often
preferred and effective modality of treatment for patients with kidney failure
that has been historically underutilized. More broadly, our methodological
approach in assessing patient distance to care will be useful in the study of
other health care services that are not equally available and accessible to all
patients.
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